Defective Viruses

Defective viruses are viral particles with genetic abnormalities or mutations that render them unable to complete their life cycle or replicate efficiently. These viruses often lack essential genes required for replication or exhibit structural defects in their genetic material. Defective viruses may arise naturally during the course of viral infections or can be intentionally engineered for therapeutic purposes. In some cases, defective viruses can interfere with the replication of their fully functional counterparts through a phenomenon known as viral interference. This interference may limit the spread of the functional virus and impact the severity of the infection. Defective viruses have been studied in the context of oncolytic virotherapy, where they are designed to selectively infect and destroy cancer cells while sparing normal cells. These engineered defective viruses can replicate in cancer cells, leading to their destruction, and may be used as potential treatments for certain types of cancers. Understanding defective viruses provides insights into viral evolution, host-virus interactions, and the development of novel therapeutic strategies for both infectious diseases and cancer. Ongoing research in this field aims to harness the potential of defective viruses for targeted and innovative medical interventions.